Targeting DAX-1 in embryonic stem cells and cancer

Bibliography

• Bardoni B, Zanaria E, Guioli S, A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994;7:497-501
   PubMedGoogle Scholar
• Adrenal hypoplasia, congenital;AHC. Online Mendelian Inheritance in Man, Baltimore, MD: Johns Hopkins University, 1986: Available from: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300200 [Last accessed 7 December 2009]
   Google Scholar
• Zanaria E, Muscatelli F, Bardoni B, An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635-41
   PubMed Web of Science ®Google Scholar
• Muscatelli F, Strom TM, Walker AP, Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-6
   PubMed Web of Science ®Google Scholar
• Habiby RL, Boepple P, Nachtigall L, Adrenal hypoplasia congenita with hypogonadotropic hypogonadism. Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996;98:1055-62
   PubMed Web of Science ®Google Scholar
• Wiltshire E, Couper J, Rodda C, Variable presentation of X-linked adrenal hypoplasia congenita. J Pediatr Endocrinol Metab 2001;14:1093-6
   Google Scholar
• Lin L, Gu WX, Ozisik G, Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. J Clin Endocrinol Metab 2006;91:3048-54
   Google Scholar
• Lalli E, Bardoni B, Zazopoulos E, A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol 1997;11:1950-60
   PubMedGoogle Scholar
• Lalli E, Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol 2003;17:1445-53
   PubMedGoogle Scholar
• Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97:161-3
   PubMed Web of Science ®Google Scholar
• Ito M, Yu R, Jameson JL. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997;17:1476-83
   PubMed Web of Science ®Google Scholar
• Lehmann SG, Lalli E, Sassone-Corsi P. X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein. Proc Natl Acad Sci USA 2002;99:8225-30
   Google Scholar
• Lehmann SG, Wurtz JM, Renaud JP, Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients. Hum Mol Genet 2003;12:1063-72
   PubMedGoogle Scholar
• Ikeda Y, Swain A, Weber TJ, Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol 1996;10:1261-72
   PubMedGoogle Scholar
• Val P, Lefrançois-Martinez AM, Veyssière G, SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl Recept 2003;1:8
   PubMedGoogle Scholar
• Zazopoulos E, Lalli E, Stocco DM, DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997;390:311-5
   PubMed Web of Science ®Google Scholar
• Verrijn Stuart AA, Ozisik G, de Vroede MA, An amino-terminal DAX1 (NR0B1) missense mutation associated with isolated mineralocorticoid deficiency. J Clin Endocrinol Metab 2007;92:755-61
   Google Scholar
• Ferraz-de-Souza B, Martin F, Mallet D, CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. J Clin Endocrinol Metab 2009;94:678-83
   Google Scholar
• Xu B, Yang WH, Gerin I, Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol Cell Biol 2009;29:1719-34
   PubMed Web of Science ®Google Scholar
• Babu PS, Bavers DL, Beuschlein F, Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002;143:665-73
   PubMed Web of Science ®Google Scholar
• Kawabe K, Shikayama T, Tsuboi H, Dax-1 as one of the target genes of Ad4BP/SF-1. Mol Endocrinol 1999;13:1267-84
   PubMedGoogle Scholar
• Lalli E, Melner MH, Stocco DM, DAX-1 blocks steroid production at multiple levels. Endocrinology 1988;139:4237-43
   Google Scholar
• Zhang H, Thomsen JS, Johansson L, DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000;275:39855-9
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kasahara M, Yoshioka H, LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol Cell Biol 2003;23:238-49
   PubMed Web of Science ®Google Scholar
• Sablin EP, Woods A, Krylova IN, The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1. Proc Natl Acad Sci USA 2008;105:18390-5
   PubMedGoogle Scholar
• Goodfellow PN, Camerino G. DAX-1, an 'antitestis' gene. Cell Mol Life Sci 1999;55:857-63
   PubMedGoogle Scholar
• Swain A, Narvaez V, Burgoyne P, Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998;391:761-7
   PubMedGoogle Scholar
• Merke DP, Tajima T, Baron J, Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med 1999;340:1248-52
   Google Scholar
• Yu RN, Ito M, Saunders TL, Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998;20:353-7
   PubMed Web of Science ®Google Scholar
• Meeks JJ, Crawford SE, Russell TA, Dax1 regulates testis cord organization during gonadal differentiation. Development 2003;130:1029-36
   PubMedGoogle Scholar
• Meeks JJ, Weiss J, Jameson JL. Dax1 is required for testis determination. Nat Genet 2003;34:32-3
   PubMed Web of Science ®Google Scholar
• Bouma GJ, Albrecht KH, Washburn LL, Gonadal sex reversal in mutant Dax1 XY mice: a failure to upregulate Sox9 in pre-Sertoli cells. Development 2005;132:3045-54
   PubMedGoogle Scholar
• Park SY, Lee EJ, Emge D, A phenotypic spectrum of sexual development in Dax1 (Nr0b1)-deficient mice: consequence of the C57BL/6J strain on sex determination. Biol Reprod 2008;79:1038-45
   PubMed Web of Science ®Google Scholar
• Seminara SB, Achermann JC, Genel M, X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999;84:4501-9
   PubMedGoogle Scholar
• Mantovani G, Ozisik G, Achermann JC, Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 2002;87:44-8
   PubMed Web of Science ®Google Scholar
• Mitsui K, Tokuzawa Y, Itoh H, The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003;113:631-42
   PubMed Web of Science ®Google Scholar
• Niakan KK, Davis EC, Clipsham RC, Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol Genet Metab 2006;88:261-71
   PubMedGoogle Scholar
• Loh YH, Wu Q, Chew JL, The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-40
   PubMed Web of Science ®Google Scholar
• Wang J, Rao S, Chu J, A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-8
   PubMed Web of Science ®Google Scholar
• Kim J, Chu J, Shen X, An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008;132:1049-61
   PubMed Web of Science ®Google Scholar
• Sun C, Nakatake Y, Ura H, Stem cell-specific expression of Dax1 is conferred by STAT3 and Oct3/4 in embryonic stem cells. Biochem Biophys Res Commun 2008;372:91-6
   PubMedGoogle Scholar
• Sun C, Nakatake Y, Akagi T, Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells. Mol Cell Biol 2009;29:4574-83
   PubMedGoogle Scholar
• Khalfallah O, Rouleau M, Barbry P, Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells 2009;27:1529-37
   PubMed Web of Science ®Google Scholar
• Xie CQ, Jeong Y, Fu M, Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol Endocrinol 2009;23:724-33
   PubMedGoogle Scholar
• Battista MC, Otis M, Côté M, Extracellular matrix and hormones modulate DAX-1 localization in the human fetal adrenal gland. J Clin Endocrinol Metab 2005;90:5426-31
   Google Scholar
• Lehmann SG, Sassone-Corsi P, Lalli E. Heat shock affects trafficking of DAX-1 by inducing its rapid and reversible cytoplasmic localization. Endocrine 2005;28:137-44
   Google Scholar
• Zubair M, Parker KL, Morohashi K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol Cell Biol 2008;28:7030-40
   PubMedGoogle Scholar
• Schulte DM, Shapiro I, Reincke M, Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal development. Gene Expr Patterns 2007;7:72-81
   PubMedGoogle Scholar
• Gummow BM, Scheys JO, Cancelli VR, Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol 2006;20:2711-23
   PubMedGoogle Scholar
• Reincke M, Beuschlein F, Lalli E, DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. J Clin Endocrinol Metab 1998;83:2597-600
   PubMedGoogle Scholar
• Lefrançois-Martinez AM, Bertherat J, Val P, Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumours. J Clin Endocrinol Metab 2004;89:3010-9
   PubMedGoogle Scholar
• Shibata H, Ikeda Y, Mukai T, Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumours: possible implications in steroidogenesis. Mol Genet Metab 2001;74:206-16
   PubMedGoogle Scholar
• Doghman M, Karpova T, Rodrigues GA, Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007;21:2968-87
   PubMedGoogle Scholar
• Doghman M, Lalli E. A matter of dosage: SF-1 in adrenocortical development and cancer. Ann Endocrinol 2009;70:148-52
   Google Scholar
• Abd-Elaziz M, Akahira J, Moriya T, Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome. Cancer Sci 2003;94:980-5
   Google Scholar
• Conde I, Alfaro JM, Fraile B, DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status. Breast Cancer Res 2004;6:R140-8
   PubMedGoogle Scholar
• Saito S, Ito K, Suzuki T, Orphan nuclear receptor DAX-1 in human endometrium and its disorders. Cancer Sci 2005;96:645-52
   Google Scholar
• Nakamura Y, Suzuki T, Arai Y, Nuclear receptor DAX1 in human prostate cancer: a novel independent biological modulator. Endocrine J 2009;56:39-44
   Google Scholar
• Helguero LA, Hedengran Faulds M, Förster C, DAX-1 expression is regulated during mammary epithelial cell differentiation. Endocrinology 2006;147:3249-59
   Google Scholar
• Seo DC, Sung JM, Cho HJ, Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer 2007;6:75. Published online 22 November 2007, doi: 10.1186/1476-4598-6-75
   PubMed Web of Science ®Google Scholar
• Hadnagy A, Gaboury L, Beaulieu R, SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006;312:3701-10
   PubMed Web of Science ®Google Scholar
• Oda T, Tian T, Inoue M, Tumourigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma. Am J Pathol 2009;175:1235-45
   Google Scholar
• Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing's family tumours. Oncogene 2001;20:5747-54
   PubMed Web of Science ®Google Scholar
• Mendiola M, Carrillo J, García E, The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumours. Int J Cancer 2006;118:1381-89
   PubMedGoogle Scholar
• García-Aragoncillo E, Carrillo J, Lalli E, DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell cycle progression in Ewing tumour cells. Oncogene 2008;27:6034-43
   PubMed Web of Science ®Google Scholar
• Gangwal K, Sankar S, Hollenhorst PC, Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci USA 2008;105:10149-54
   PubMed Web of Science ®Google Scholar
• Kinsey M, Smith R, Lessnick SL. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 2006;4:851-9
   PubMed Web of Science ®Google Scholar
• Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49
   PubMed Web of Science ®Google Scholar
• Lepourcelet M, Chen YN, France DS, Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 2004;5:91-102
   PubMed Web of Science ®Google Scholar
• Zhou J, Oakley RH, Cidlowski JA. DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner. Mol Endocrinol 2008;22:1521-34
   Google Scholar
• Holter E, Kotaja N, Mäkela S, Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol 2002;16:515-28
   PubMedGoogle Scholar
• Agoulnik IU, Krause WC, Bingman WE III, Repressors of androgen and progesterone receptor action. J Biol Chem 2003;278:31136-48
   PubMed Web of Science ®Google Scholar
• Song KH, Park YY, Park KC, The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol Endocrinol 2004;18:1929-40
   PubMed Web of Science ®Google Scholar
• Lopez D, Shea-Eaton W, Sanchez MD, DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1. Endocrinology 2001;142:5097-106
   PubMedGoogle Scholar
• Iyer AK, Zhang YH, McCabe ER. Dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX1) (NR0B1) and small heterodimer partner (SHP) (NR0B2) form homodimers individually, as well as DAX1-SHP heterodimers. Mol Endocrinol 2006;20:2326-42
   Google Scholar
• Park YY, Ahn SW, Kim HJ, An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRgamma. Nucleic Acids Res 2005;33:6756-68
   PubMedGoogle Scholar
• Kim GS, Lee GY, Nedumaran B, The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma. Biochem Biophys Res Commun 2008;370:264-8
   Google Scholar
• Nedumaran B, Hong S, Xie YB, DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates the gluconeogenic enzyme gene expression. J Biol Chem 2009;284:27511-23
   Google Scholar
• Altincicek B, Tenbaum SP, Dressel U, Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem 2000;275:7662-7
   PubMedGoogle Scholar
• Sugawara T, Abe S, Sakuragi N, RIP 140 modulates transcription of the steroidogenic acute regulatory protein gene through interactions with both SF-1 and DAX-1. Endocrinology 2001;142:3570-7
   PubMedGoogle Scholar
• Crawford PA, Dorn C, Sadovsky Y, Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998;18:2949-56
   PubMed Web of Science ®Google Scholar
• Tamai KT, Monaco L, Alastalo TP, Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 1996;10:1561-9
   PubMedGoogle Scholar